US6194140B1
(en)
|
1990-04-04 |
2001-02-27 |
Chiron Corporation |
HCV NS3 protein fragments having helicase activity and improved solubility
|
EP0527788B1
(de)
*
|
1990-04-04 |
2004-06-30 |
Chiron Corporation |
Protease von hepatitis-c-virus
|
DE69132332T2
(de)
*
|
1990-04-06 |
2000-11-30 |
Genelabs Tech Inc |
Hepatitis c-virus-epitope
|
UA40572C2
(uk)
|
1991-06-24 |
2001-08-15 |
Чірон Корпорейшн |
Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
|
DE4428705A1
(de)
*
|
1994-08-12 |
1996-02-15 |
Boehringer Mannheim Gmbh |
Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
|
US5861267A
(en)
*
|
1995-05-01 |
1999-01-19 |
Vertex Pharmaceuticals Incorporated |
Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
|
US5767233A
(en)
*
|
1995-05-12 |
1998-06-16 |
Schering Corporation |
Soluble cleavable substrates of the hepatitis C virus protease
|
US5843752A
(en)
*
|
1995-05-12 |
1998-12-01 |
Schering Corporation |
Soluble active hepatitis C virus protease
|
US5698396A
(en)
*
|
1995-06-07 |
1997-12-16 |
Ludwig Institute For Cancer Research |
Method for identifying auto-immunoreactive substances from a subject
|
IT1277914B1
(it)
*
|
1995-08-22 |
1997-11-12 |
Angeletti P Ist Richerche Bio |
Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
|
US6127116A
(en)
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
US7235394B1
(en)
|
1995-08-29 |
2007-06-26 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
CA2244372A1
(en)
*
|
1996-01-23 |
1997-07-31 |
Marc S. Collett |
Methods for identifying inhibitors of rna viruses
|
US5766916A
(en)
*
|
1996-04-24 |
1998-06-16 |
Genelabs Technologies, Inc. |
Hepatitis G virus protease
|
US5990276A
(en)
*
|
1996-05-10 |
1999-11-23 |
Schering Corporation |
Synthetic inhibitors of hepatitis C virus NS3 protease
|
US5861297A
(en)
*
|
1996-09-27 |
1999-01-19 |
Merck & Co., Inc. |
Detergent-free hepatitis C protease
|
AU4904397A
(en)
*
|
1996-10-17 |
1998-05-11 |
Chiron Corporation |
Protease regulator screening assay
|
US7049428B1
(en)
*
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
US5849800A
(en)
*
|
1997-03-28 |
1998-12-15 |
The Penn State Research Foundation |
Use of amantadine for treatment of Hepatitis C
|
US20020034732A1
(en)
*
|
1997-07-30 |
2002-03-21 |
Daniel J. Capon |
Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
|
BR9908540A
(pt)
*
|
1998-01-30 |
2000-11-28 |
Gen Hospital Corp |
Molécula de ácido nucleico recombinante, célula hospedeira recombinante, composição farmacêutica, e, processo para induzir uma resposta imune contra vìrus de hepatite c em um humano não infectado por vìrus de hepatite c, para imunizar um humano suscetìvel a vìrus de hepatite c, e para tratar um humano que é infectado com vìrus de hepatite c
|
US7078500B1
(en)
*
|
1998-01-30 |
2006-07-18 |
The General Hospital Corporation |
Genetic immunization with nonstructural proteins of hepatitis C virus
|
JP2002510509A
(ja)
*
|
1998-04-02 |
2002-04-09 |
バイロファーマ・インコーポレイテッド |
C型肝炎ウイルスns5b組成物およびその使用方法
|
TR200003024T2
(tr)
|
1998-04-17 |
2000-12-21 |
Innogenetics N.V. |
İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
|
US6280940B1
(en)
|
1998-08-05 |
2001-08-28 |
Agouron Pharmaceuticals, Inc. |
Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
|
AU2217800A
(en)
*
|
1998-12-24 |
2000-07-31 |
Small Molecule Therapeutics, Inc. |
Methods and compositions for identifying protease modulators
|
IL143798A0
(en)
|
1999-01-08 |
2002-04-21 |
Bristol Myers Squibb Co |
Hepatitis c virus ns3 protease
|
DE60034884T2
(de)
*
|
1999-06-04 |
2008-01-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
|
US7084266B1
(en)
|
1999-06-04 |
2006-08-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof
|
WO2001035316A2
(en)
*
|
1999-11-10 |
2001-05-17 |
Structural Bioinformatics, Inc. |
Computationally derived protein structures in pharmacogenomics
|
US20060141480A1
(en)
*
|
1999-11-10 |
2006-06-29 |
Kalyanaraman Ramnarayan |
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics and clinical applications
|
US6986892B1
(en)
*
|
1999-11-24 |
2006-01-17 |
Chiron Corporation |
Immunogenic Hepatitis C virus non-structural polypeptides
|
US20050074465A1
(en)
*
|
1999-11-24 |
2005-04-07 |
Michael Houghton |
HCV fusion proteins with modified NS3 domains
|
HUP0400456A3
(en)
|
2000-04-05 |
2005-09-28 |
Schering Corp |
Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties and pharmaceutical compositions containing them
|
CN1432022A
(zh)
|
2000-04-19 |
2003-07-23 |
先灵公司 |
含有烷基和芳基丙氨酸p2部分的丙型肝炎病毒的大环ns3-丝氨酸蛋白酶抑制剂
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EP1160332A1
(de)
*
|
2000-05-30 |
2001-12-05 |
Amsterdam Support Diagnostics B.V. |
Verfahren zum Nachweis von enzymatischer Aktivität oder von Resistenz gegen enzymatiche Inhibitoren
|
US7491808B2
(en)
*
|
2000-06-15 |
2009-02-17 |
Novartis Vaccines And Diagnostics, Inc. |
HCV non-structural protein mutants and uses thereof
|
AU8063701A
(en)
*
|
2000-07-21 |
2002-02-05 |
Schering Corp |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
CA2418199A1
(en)
*
|
2000-07-21 |
2002-01-31 |
Corvas International, Inc. |
Peptides as ns3-serine protease inhibitors of hepatitis c virus
|
SI1385870T1
(sl)
*
|
2000-07-21 |
2010-08-31 |
Schering Corp |
Peptidi kot NS3-serin proteazni inhibitorji virusa hepatitisa C
|
US6960569B2
(en)
|
2000-08-17 |
2005-11-01 |
Tripep Ab |
Hepatitis C virus non-structural NS3/4A fusion gene
|
US6858590B2
(en)
*
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US6680059B2
(en)
*
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
MXPA03005219A
(es)
|
2000-12-12 |
2003-09-25 |
Schering Corp |
Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c.
|
WO2003026589A2
(en)
*
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
ES2332778T3
(es)
*
|
2002-01-23 |
2010-02-12 |
Schering Corporation |
Compuestos de prolina como inhibidores de la proteasa serina ns3 para uso en el tratamiento de infeccion por el virus de la hepatitis c.
|
CA2481502A1
(en)
*
|
2002-04-04 |
2003-10-16 |
Achillion Pharmaceuticals, Inc. |
Hcv antiviral and cytotoxicity drug screening assay
|
US7666627B2
(en)
*
|
2002-08-08 |
2010-02-23 |
Targetex Kft. |
Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof
|
US7439042B2
(en)
*
|
2002-12-16 |
2008-10-21 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis C infection
|
EP1633871A4
(de)
*
|
2003-06-03 |
2010-02-17 |
Benitec Australia Ltd |
Doppelsträngige nukleinsäure
|
WO2005017125A2
(en)
*
|
2003-08-14 |
2005-02-24 |
California Institute Of Molecular Medicine |
Method for isolation and replication of infectious human hepatitis-c virus
|
US7449447B2
(en)
*
|
2003-08-26 |
2008-11-11 |
Schering Corporation |
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
|
JP4525982B2
(ja)
|
2003-09-26 |
2010-08-18 |
シェーリング コーポレイション |
C型肝炎ウイルスのns3セリンプロテアーゼの大環状インヒビター
|
US20110150835A1
(en)
*
|
2003-09-26 |
2011-06-23 |
Schering Corporation |
Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
|
JP2007532479A
(ja)
*
|
2003-11-20 |
2007-11-15 |
シェーリング コーポレイション |
C型肝炎ウイルスns3プロテアーゼの脱ペプチド化インヒビター
|
RU2006134005A
(ru)
*
|
2004-02-27 |
2008-04-10 |
Шеринг Корпорейшн (US) |
Новые соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
|
US7816326B2
(en)
*
|
2004-02-27 |
2010-10-19 |
Schering Corporation |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
|
JP2007525511A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼの新規のインヒビターとしての化合物
|
CN1950393A
(zh)
*
|
2004-02-27 |
2007-04-18 |
先灵公司 |
丙型肝炎病毒ns3蛋白酶的抑制剂
|
JP2007525512A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼのインヒビターとしての3,4−(シクロペンチル)−縮合プロリン化合物
|
PL1730110T3
(pl)
*
|
2004-02-27 |
2010-11-30 |
Merck Sharp & Dohme |
Siarkowe związki jako inhibitory proteazy serynowej NS3 wirusa zapalenia wątroby typu C
|
KR101246862B1
(ko)
*
|
2004-03-05 |
2013-03-27 |
베니텍 리미티드 |
RNAi 제제의 동시 전달을 위한 다중 프로모터 발현카세트
|
WO2005107745A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Schering Corporation |
An inhibitor of hepatitis c
|
CN1984922A
(zh)
|
2004-05-20 |
2007-06-20 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的取代脯氨酸
|
CN101068828A
(zh)
*
|
2004-08-27 |
2007-11-07 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的酰基磺酰胺化合物
|
JP2008516610A
(ja)
|
2004-10-18 |
2008-05-22 |
グローブイミューン,インコーポレイテッド |
酵母を用いた慢性c型肝炎感染の治療
|
WO2006121468A1
(en)
*
|
2004-11-22 |
2006-11-16 |
Genelabs Technologies, Inc. |
5-nitro-nucleoside compounds for treating viral infections
|
JP2008531703A
(ja)
*
|
2005-02-28 |
2008-08-14 |
ジェネラブズ テクノロジーズ インコーポレーティッド |
ウイルス感染症の治療のための三環式ヌクレオシドプロドラッグ
|
WO2006116557A1
(en)
*
|
2005-04-25 |
2006-11-02 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
US7968697B2
(en)
*
|
2005-05-25 |
2011-06-28 |
Chrontech Pharma Ab |
Hepatitis C virus non-structural NS3/4A fusion gene
|
US20070237818A1
(en)
*
|
2005-06-02 |
2007-10-11 |
Malcolm Bruce A |
Controlled-release formulation of HCV protease inhibitor and methods using the same
|
JP5160415B2
(ja)
*
|
2005-06-02 |
2013-03-13 |
メルク・シャープ・アンド・ドーム・コーポレーション |
医薬処方物およびそれを用いる治療方法
|
PL1891089T3
(pl)
|
2005-06-02 |
2015-05-29 |
Merck Sharp & Dohme |
Inhibitory proteazy HCV w połączeniu z pokarmem
|
US20060293320A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Genelabs Technologies, Inc. |
Heteroaryl derivatives for treating viruses
|
TW200808308A
(en)
*
|
2006-02-09 |
2008-02-16 |
Schering Corp |
Novel HCV inhibitor combinations and methods
|
EP1998765A2
(de)
*
|
2006-03-03 |
2008-12-10 |
Schering Corporation |
Pharmazeutische kombinationen aus hcv-protease- und -ires-hemmern
|
WO2007111866A2
(en)
*
|
2006-03-23 |
2007-10-04 |
Schering Corporation |
Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto
|
US7825152B2
(en)
|
2006-04-11 |
2010-11-02 |
Novartis Ag |
Organic compounds and their uses
|
US20080045498A1
(en)
*
|
2006-07-20 |
2008-02-21 |
Genelabs Technologies, Inc. |
Polycyclic viral inhibitors
|
EP2185195A2
(de)
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Immunogen-plattform
|
WO2009029729A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Genelabs Technologies, Inc. |
Amino tricyclic-nucleoside compounds, compositions, and methods of use
|
AU2008318618A1
(en)
*
|
2007-10-30 |
2009-05-07 |
Intermune, Inc. |
HCV genotyping and phenotyping
|
CA2710144A1
(en)
|
2007-12-21 |
2009-07-02 |
Avila Therapeutics, Inc. |
Hcv protease inhibitors and uses thereof
|
CN104557861A
(zh)
*
|
2007-12-21 |
2015-04-29 |
阿维拉制药公司 |
Hcv蛋白酶抑制剂和其用途
|
US8293705B2
(en)
|
2007-12-21 |
2012-10-23 |
Avila Therapeutics, Inc. |
HCV protease inhibitors and uses thereof
|
US8309685B2
(en)
*
|
2007-12-21 |
2012-11-13 |
Celgene Avilomics Research, Inc. |
HCV protease inhibitors and uses thereof
|
US7699111B2
(en)
*
|
2008-01-29 |
2010-04-20 |
Tam International, Inc. |
Float collar and method
|
WO2009130588A2
(en)
*
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Immunogen platform
|
EP2307419B1
(de)
|
2008-06-24 |
2013-11-06 |
Codexis, Inc. |
Biokatalytische verfahren zur herstellung substantiell stereomer reiner, kondensierter und bizyklischer prolinverbindungen
|
US8188137B2
(en)
|
2008-08-15 |
2012-05-29 |
Avila Therapeutics, Inc. |
HCV protease inhibitors and uses thereof
|
JP2012503011A
(ja)
|
2008-09-19 |
2012-02-02 |
グローブイミューン,インコーポレイテッド |
慢性c型肝炎ウイルス感染の免疫療法
|
WO2010068714A2
(en)
|
2008-12-12 |
2010-06-17 |
Schering Corporation |
Deuterated compounds as hepatitis c virus (hcv) inhibitors
|
US20110027229A1
(en)
|
2009-07-31 |
2011-02-03 |
Medtronic, Inc. |
Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients
|
AR082453A1
(es)
|
2010-04-21 |
2012-12-12 |
Novartis Ag |
Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
|
MX2013000906A
(es)
|
2010-07-22 |
2013-02-27 |
Novartis Ag |
Compuestos de tiofeno 2, 3, 5-trisustituidos y usos de los mismos.
|
WO2012092484A2
(en)
|
2010-12-29 |
2012-07-05 |
Inhibitex, Inc. |
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
|
KR101784455B1
(ko)
|
2015-12-04 |
2017-10-11 |
주식회사 바이오노트 |
C형 간염 바이러스의 친수성 단편을 포함하는 융합 폴리펩티드, 그를 포함하는 c형 간염 바이러스 감염을 진단하기 위한 조성물, 키트, 및 방법
|